Publications

Malinga J, Braunack-Mayer L, Masserey T, Cavelan A, Chandramohan D, Dicko A, Ouédraogo J.B, Kelly S.L, Le Rutte E.A, Nekkab N, Penny M.A. Performance characteristics and potential public health impact of improved pre-erythrocytic malaria vaccines targeting childhood burden. PLOS Glob Public Health. 2025;5(8):e0004549. DOI: 10.1371/journal.pgph.0004549

Masserey T, Braunack-Mayer L, Miller R.S, Möhrle J.J, Penny M.A. A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention. Parasitology. 2025;152(2):133-142. DOI: 10.1017/s0031182025000071

Sen S, Braunack-Mayer L, Kelly S.L, Masserey T, Malinga J, Moehrle J.J, Penny M.A. Public health impact of current and proposed age-expanded perennial malaria chemoprevention: a modelling study. Sci Rep. 2025;15:10488. DOI: 10.1038/s41598-025-93623-z

Shirima G, Masserey T, Gervas H, Chitnis N, Kiware S, Mirau S. Assessing the role of community involvement and capacity building in larviciding applications for malaria control in Africa: a scoping review. Curr Res Parasitol Vector Borne Dis. 2025;8:100307. DOI: 10.1016/j.crpvbd.2025.100307

Braunack-Mayer L, Malinga J, Masserey T, Nekkab N, Sen S, Schellenberg D, Tchouatieu A.M, Kelly S.L, Penny M.A. Design and selection of drug properties to increase the public health impact of next-generation seasonal malaria chemoprevention: a modelling study. Lancet Glob Health. 2024;12(3):e478-e490. DOI: 10.1016/s2214-109x(23)00550-8

Masserey T, Lee T, Kelly S.L, Hastings I.M, Penny M.A. Seasonal malaria chemoprevention and the spread of Plasmodium falciparum quintuple-mutant parasites resistant to sulfadoxine-pyrimethamine: a modelling study. Lancet Microbe. 2024;5(9):100892. DOI: 10.1016/s2666-5247(24)00115-0

Masserey T, Lee T, Golumbeanu M, Shattock A.J, Kelly S.L, Hastings I.M, Penny M.A. The influence of biological, epidemiological, and treatment factors on the establishment and spread of drug-resistant Plasmodium falciparum. eLife. 2022;11:e7763. DOI: 10.7554/eLife.77634

Masserey T, Penny M.A, Lee T.E. Patient variability in the blood-stage dynamics of Plasmodium falciparum captured by clustering historical data. Malar J. 2022;21:300. DOI: 10.1186/s12936-022-04317-0

Masserey T. Investigating patient variability in blood-stage vaccine efficacy against clinical malaria caused by Plasmodium falciparum. Basel: Swiss Tropical and Public Health Institute, 2019. MSc Thesis